2-Amino-9-[(1R,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one(CAS: 1367369-76-3)

This compound is subject to various regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a pharmaceutical intermediate and may be regulated under the Toxic Substances Control Act (TSCA) in the US. Manufacturers and users should adhere to specific handling, storage, and disposal guidelines as outlined by these regulations.

There are several alternatives in synthesis, including using related analogs such as 2-Amino-9-(3,3-dimethylcyclohex-1-en-1-yl)-1,9-dihydro-6H-purin-6-one and other 2-aminopurine derivatives. Common alternative reagents include substituted amines and cyclopentyl derivatives, which can provide similar functional groups but with different structural properties.

The market trend for this compound reflects increasing research interest in purine-based compounds for medicinal applications. Recent studies are focusing on its potential as an antiviral agent and as a lead compound in drug discovery. Market trends suggest growing demand for such intermediates, although price fluctuations may vary based on supply and demand dynamics.

Waste containing this compound should be collected in appropriate containers and stored under controlled conditions to prevent environmental contamination. Proper incineration or professional waste disposal services should be utilized for safe disposal. Environmental protection measures include ensuring compliance with local regulations and using protective equipment to minimize exposure. Training for personnel involved in handling and disposal is also crucial.